A patient of pulmonary tuberculosis was put on anti-tuberculosis therapy. He was given Rifampicin, INH, Ethambutol and Pyrazinamide He should be advised to have a supplement of
**Core Concept**
Pulmonary tuberculosis treatment involves a combination of antibiotics to prevent resistance and ensure effective treatment. The patient is on a standard first-line regimen of anti-tuberculosis therapy, which includes rifampicin, isoniazid (INH), ethambutol, and pyrazinamide.
**Why the Correct Answer is Right**
The patient should be advised to take vitamin B6 (pyridoxine) supplements as a prophylactic measure to prevent peripheral neuropathy, a common side effect of isoniazid. Isoniazid can interfere with pyridoxine metabolism, leading to a deficiency and subsequent neuropathic symptoms. Supplementing with pyridoxine can help mitigate this risk.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because there is no direct association between the patient's medication regimen and a need for calcium supplements.
**Option B:** This option is incorrect because while vitamin D is essential for bone health, it is not directly related to the patient's anti-tuberculosis therapy.
**Option C:** This option is incorrect because there is no indication that the patient requires a supplement of folic acid, which is often associated with methotrexate therapy.
**Clinical Pearl / High-Yield Fact**
It is essential to note that patients on isoniazid therapy should be advised to take pyridoxine supplements to prevent peripheral neuropathy, especially if they have a history of malnutrition or are taking other medications that may interfere with pyridoxine metabolism.
**Correct Answer:** A. Pyridoxine (Vitamin B6)